DFCI @ South Shore Hospital

South Weymouth, Massachusetts 02190

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Breast Cancer Female, Breast Cancer Metastatic, HER2-positive Breast Cancer, Her 2 Positive Breast Cancer, Metastatic Breast Cancer, Metastatic Non Small Cell Lung Cancer

Studies at this site

• STOP-HER2: Stopping Trastuzumab in HER2+ MBC — Running, not enrolling
• Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations — Running, not enrolling
• A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN) — Running, not enrolling